Cargando...
The Effect of Hydroxyurea Therapy in Bahraini Sickle Cell Disease Patients
Hydroxyurea (HU) is used as a disease-modifying agent in sickle cell disease (SCD). Its beneficial effects have been ascribed to inhibition of the sickling process through increase of fetal hemoglobin (HbF) levels and influence on multiple factors affecting adhesion of erythrocytes to vascular endot...
Guardado en:
| Publicado en: | Indian J Hematol Blood Transfus |
|---|---|
| Autores principales: | , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Springer India
2015
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4733670/ https://ncbi.nlm.nih.gov/pubmed/26855516 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12288-015-0529-y |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|